News Features Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond Shelley Wood December 30, 2016
News Features Repaso del Año: Los Médicos Eligen las Noticias Más Importantes de 2016 en Cardiología Intervencionista y Más Shelley Wood December 30, 2016
News Daily News High-Sensitivity Troponin Assays May Help With Response to Statins and Other Meds Todd Neale December 19, 2016
News Daily News Statins Seem to Reduce Alzheimer’s Disease Risk, But Race/Ethnicity and Statin Type Matter Todd Neale December 14, 2016
News Daily News Al parecer las estatinas reducen el riesgo de la Enfermedad de Alzheimer, pero se deben tener en cuenta el tipo de estatina y la raza/etnicidad. Todd Neale December 14, 2016
News Daily News High-Intensity Statin Therapy Offers Survival Benefit Over Moderate-Intensity Statins in CVD Patients Michael O'Riordan November 10, 2016
News Daily News El Tratamiento con Estatinas de Alta Intensidad Ofrece una Mayor Supervivencia sobre las Estatinas de Intensidad Moderada en Pacientes con Enfermedad Cardiovascular Michael O'Riordan November 10, 2016
News Conference News TCT 2016 YELLOW II: Improved Cholesterol Efflux Linked to Plaque Stabilization in Statin-Treated Patients Michael O'Riordan October 29, 2016
News Daily News FH Screening Started at Time of Childhood Immunization Feasible and Effective Michael O'Riordan October 28, 2016
News Daily News La AHA Facilita las Interacciones Farmacológicas entre Estatinas y Fármacos contra la Enfermedad Cardiovascular Michael O'Riordan October 18, 2016
News Daily News AHA Provides Guidance on Drug-Drug Interactions With Statins and CVD Medications Michael O'Riordan October 18, 2016
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for September 2016 Shelley Wood September 30, 2016
News Daily News TCTMD’s Top 10 Most Popular Stories for September 2016 Shelley Wood September 30, 2016
News Daily News Pharmacist Management of High Cholesterol Gets More Patients to Goal, Lowers LDL Levels: RxACT Michael O'Riordan September 29, 2016
News Daily News Lowering LDL With Statins and Other Selected Agents Should Be Focus of CVD Risk Reduction, Analysis Implies Michael O'Riordan September 27, 2016
News Daily News CAC Screening Stratifies CVD Event Risk in Statin-Eligible Patients: Heinz Nixdorf Recall Study Michael O'Riordan September 22, 2016